These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2085833)

  • 1. Ischaemically induced alterations in electrical activity and mechanical performance of isolated blood perfused canine myocardial preparations.
    Himori N; Walls AP; Burkman AM
    Cardiovasc Res; 1990 Oct; 24(10):786-92. PubMed ID: 2085833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of Bay k 8644, a presumed calcium channel activator, on sinoatrial nodal and ventricular automaticity of the dog heart.
    Satoh K; Wada Y; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):190-2. PubMed ID: 6206405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
    Gotanda K; Yanagisawa T; Satoh K; Taira N
    Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle.
    Gasser RN; Vaughan-Jones RD
    J Physiol; 1990 Dec; 431():713-41. PubMed ID: 2129231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y; Taira N
    Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effects of amiloride in the dog.
    Yamashita S; Motomura S; Taira N
    J Cardiovasc Pharmacol; 1981; 3(4):704-15. PubMed ID: 6167801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
    Satoh K; Yanagisawa T; Taira N
    Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).
    Taira N; Satoh K; Yanagisawa T; Imai Y; Hiwatari M
    Clin Exp Pharmacol Physiol; 1979; 6(3):301-16. PubMed ID: 157241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Hashimoto K
    Jpn J Pharmacol; 1991 May; 56(1):1-12. PubMed ID: 1908917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
    Satoh K; Kawada M; Wada Y; Taira N
    Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.
    Sato Y; Wada Y; Taira N
    Heart Vessels; 1986; 2(4):213-20. PubMed ID: 3571104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.